|
2023
|
Invention
|
Compositions and methods for inhibiting expression of mutant egfr gene.
The invention relates to... |
|
2022
|
Invention
|
Tgf-β3 specific antibodies and methods and uses thereof. Specific binding members, particularly a... |
|
|
Invention
|
Enhanced immune cell receptor sequencing methods.
Disclosed are methods for sequencing immune ce... |
|
2021
|
Invention
|
Parallel analysis of individual cells for rna expression and dna from targeted tagmentation by se... |
|
|
Invention
|
Methods and compositions for modulating angiogenesis and pericyte composition.
In certain aspect... |
|
|
Invention
|
Tgf-β1 specific antibodies and methods and uses thereof. Specific binding members, particularly a... |
|
2020
|
Invention
|
Method of treating cancer.
The present disclosure provides a method for enhancing or inducing an... |
|
|
Invention
|
Anti-tem1 antibodies and antigen-binding portions thereof. Provided herein are antibodies and ant... |
|
2018
|
Invention
|
Methods and systems for analyzing time ordered image data. A method for characterising motion of ... |
|
|
Invention
|
Method of treating cancer.
The present disclosure provides computer-implemented methods of organ... |
|
|
Invention
|
Tgf-ß1 specific antibodies and methods and uses thereof. Specific binding members, particularly a... |
|
|
Invention
|
Anti-metalloprotease antibody for diagnosis and treatment of cancers. Expression of proteolytical... |
|
|
Invention
|
Reversible protein multimers, methods for their production and use. Some aspect of this disclosur... |
|
|
Invention
|
Kinase mutants and uses thereof. The present invention relates to methods of designing kinase mut... |
|
|
Invention
|
Enhanced immune cell receptor sequencing methods. Disclosed are methods for sequencing immune cel... |
|
2016
|
Invention
|
Liposomal formulation of nonglycosidic ceramides and uses thereof. The invention provides liposom... |
|
|
P/S
|
Medical research, namely, research relating to the study,
treatment, detection and prevention of... |
|
2015
|
Invention
|
Compositions and methods for inhibiting expression of mutant egfr gene. The invention relates to ... |
|
|
Invention
|
Membrane transporter napi2b (scl34a2) epitope for antibody therapy, antibodies directed thereto, ... |
|
2014
|
Invention
|
Method of treating cancer. The present disclosure provides a method for enhancing or inducing an ... |
|
2013
|
Invention
|
Methods of predicting outcome and treating breast cancer. Described herein are materials, methods... |
|
|
Invention
|
Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antige... |
|
|
P/S
|
Medical research, namely, research relating to the study, treatment, detection and prevention of ... |
|
|
Invention
|
Method of treatment.
The present invention relates generally to the field of cancer therapy. Mor... |
|
|
Invention
|
Mif for use in methods of treating subjects with a neurodegenerative disorder. Described herein a... |
|
|
Invention
|
Iaspp phosphorylation and metastatic potential. Described herein are methods of evaluating metast... |
|
2012
|
Invention
|
Cleavage inhibitors of transforming growth factor beta type i receptor and uses thereof in cancer... |
|
2011
|
Invention
|
Liposomal formulation of nonglycosidic ceramides and uses thereof.
The invention provides liposo... |
|
|
Invention
|
Reversible protein multimers, methods for their production and use. Some aspects of this inventio... |
|
|
Invention
|
Recombinant trypanosoma cruzi cells useful as anti-cancer immune agents.
Recombinant, attenuated... |
|
2010
|
Invention
|
Cancer testis antigens as biomarkers in non-small cell lung cancer.
A cancer testis antigen biom... |
|
|
Invention
|
Immunodominant mhc dr52b restricted ny-eso-1 epitopes, mhc class ii monomers and multimers, and u... |
|
|
Invention
|
Anti-fibroblast activation protein antibodies and methods and uses thereof. Specific binding memb... |
|
|
Invention
|
Seromic analysis of ovarian cancer.
The invention relates to the discovery of cancer antigens as... |
|
1991
|
P/S
|
live transgenic mice |
